Advertisement
Screener

Paymentus Holdings, Inc. (PAY) Spending and interest coverage

Paymentus Holdings, Inc. (PAY) Spending and interest coverage

  • R&D / revenue · 12 months: Value 4.62%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 1.69%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months4.62%Research and development expense / revenue. Period ending 2026-06-30.

$62.79M ÷ $1.36B × 100 ≈ 4.62%

Stock-based compensation / revenue · 12 months1.69%Share-based compensation / revenue. Period ending 2026-06-30.

$23.02M ÷ $1.36B × 100 ≈ 1.69%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending62.79M USDResearch and Development Expense
Revenue1.36B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation23.02M USDShare-based Payment Arrangement, Noncash Expense
Operating income103.10M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$62.79M$1.36B$23.02M$103.10M(m)4.62%1.69%(m)(m)
2026-03-31$62.71M$1.28B$21.28M$86.40M(m)4.90%1.66%(m)(m)
2025-12-31$61.47M$1.20B$18.63M$75.54M(m)5.14%1.56%(m)(m)
2025-09-30$59.11M$1.12B$15.93M$65.66M(m)5.26%1.42%(m)(m)
2025-06-30$57.08M$1.04B$13.46M$57.89M(m)5.46%1.29%(m)(m)
2025-03-31$54.38M$962.11M$11.57M$52.20M(m)5.65%1.20%(m)(m)
2024-12-31$51.33M$871.75M$10.99M$44.86M(m)5.89%1.26%(m)(m)
2024-09-30$48.43M$778.67M$11.92M$39.81M(m)6.22%1.53%(m)(m)
2024-06-30$46.27M$699.52M$11.21M$33.03M(m)6.62%1.60%(m)(m)
2024-03-31$44.65M$651.04M$10.16M$27.42M(m)6.86%1.56%(m)(m)
2023-12-31$44.25M$614.49M$9.39M$18.09M(m)7.20%1.53%(m)(m)
2023-09-30$43.89M$581.87M$9.01M$10.49M(m)7.54%1.55%(m)(m)
2023-06-30$43.20M$557.60M$8.55M$4.26M(m)7.75%1.53%(m)(m)
2023-03-31$42.48M$528.63M$7.62M$-2.59M(m)8.04%1.44%(m)(m)
2022-12-31$41.22M$497.00M$6.74M$-2.98M(m)8.29%1.36%(m)(m)
2022-09-30$40.58M$472.96M$5.87M$-4.20M(m)8.58%1.24%(m)(m)
2022-06-30$39.05M$446.48M$4.63M$-2.16M(m)8.75%1.04%(m)(m)
2022-03-31$36.78M$420.01M$3.85M$4.15M(m)8.76%0.92%(m)(m)
2021-12-31$34.12M$395.52M$3.14M$10.37M(m)8.63%0.79%(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31$24.51M$301.77M$1.99M$18.43M(m)8.12%0.66%(m)(m)
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31$17.86M$235.78M$1.58M$18.37M(m)7.58%0.67%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.